Recent advances in clinical aspects of in vitro fertilisation.
While early success rates using in vitro fertilisation ranged from 10% to 15%, improved technology has more than doubled that rate, owing to the availability of recombinant follicle-stimulating hormone, improved ovarian stimulation protocols, and assisted fertilisation technology. This latter technology has already revolutionised the management of male-factor infertility. The future goal is to further increase the overall pregnancy rate and to reduce the risk of multiple gestation by using pre-implantation genetic diagnosis and blastocyst transfer.
Leung
C K
CK
IVF Centre, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong.
D005260:Female; D005307:Fertilization in Vitro; D005640:Follicle Stimulating Hormone / Q000097:blood / Q000494:pharmacology; D007987:Gonadotropin-Releasing Hormone / Q000037:antagonists & inhibitors; D006801:Humans; D007986:Luteinizing Hormone / Q000097:blood / Q000494:pharmacology; D008297:Male; D009865:Oocytes / Q000502:physiology; D016133:Polymerase Chain Reaction; D011247:Pregnancy; D011379:Prognosis; D011994:Recombinant Proteins / Q000494:pharmacology; D020554:Sperm Injections, Intracytoplasmic
D011994:Recombinant Proteins; D007987:Gonadotropin-Releasing Hormone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone